---
figid: PMC9028246__cells-11-01370-g004
figtitle: 'Genomic Hippo Pathway Alterations and Persistent YAP/TAZ Activation: New
  Hallmarks in Head and Neck Cancer'
organisms:
- Nicotiana tabacum
- Lareunionomyces loeiensis
- Human gammaherpesvirus 4
- Human papillomavirus
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
organisms_ner:
- Mus musculus
- Drosophila melanogaster
- Homo sapiens
- Danio rerio
pmcid: PMC9028246
filename: cells-11-01370-g004.jpg
figlink: /pmc/articles/PMC9028246/figure/cells-11-01370-f004/
number: F4
caption: Targeting Hippo and YAP/TAZ. Therapeutic agents promoting Hippo activation
  or YAP/TAZ inhibition are shown in red. Grey arrows and molecules indicate inhibition
  of downstream processes. Cetuximab-mediated EGFR inhibition, Alpelisib-mediated
  PI3K inhibition, Dasatinib-mediated SRC inhibition, Defactinib and IN10018-mediated
  FAK inhibition, and Trametinib-mediated MEK inhibition relieve Hippo-inhibitory
  inputs and enable Hippo signaling to inhibit YAP/TAZ. Tankyrase inhibitors prevent
  proteolytic degradation of AMOT, enabling AMOT to activate Hippo signaling. Small
  molecule TEAD inhibitors (smTEADi) prevent YAP/TAZ:TEAD interaction by inhibiting
  TEAD autopalmitoylation. Verteporfin inhibits YAP/TAZ:TEAD interaction [,,,,,,,,].
papertitle: 'Genomic Hippo Pathway Alterations and Persistent YAP/TAZ Activation:
  New Hallmarks in Head and Neck Cancer.'
reftext: Farhoud Faraji, et al. Cells. 2022 Apr;11(8):1370.
year: '2022'
doi: 10.3390/cells11081370
journal_title: Cells
journal_nlm_ta: Cells
publisher_name: MDPI
keywords: head and neck squamous cell carcinoma | HNSC | HNSCC | Hippo | YAP | TAZ
  | FAT1
automl_pathway: 0.9147348
figid_alias: PMC9028246__F4
figtype: Figure
redirect_from: /figures/PMC9028246__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9028246__cells-11-01370-g004.html
  '@type': Dataset
  description: Targeting Hippo and YAP/TAZ. Therapeutic agents promoting Hippo activation
    or YAP/TAZ inhibition are shown in red. Grey arrows and molecules indicate inhibition
    of downstream processes. Cetuximab-mediated EGFR inhibition, Alpelisib-mediated
    PI3K inhibition, Dasatinib-mediated SRC inhibition, Defactinib and IN10018-mediated
    FAK inhibition, and Trametinib-mediated MEK inhibition relieve Hippo-inhibitory
    inputs and enable Hippo signaling to inhibit YAP/TAZ. Tankyrase inhibitors prevent
    proteolytic degradation of AMOT, enabling AMOT to activate Hippo signaling. Small
    molecule TEAD inhibitors (smTEADi) prevent YAP/TAZ:TEAD interaction by inhibiting
    TEAD autopalmitoylation. Verteporfin inhibits YAP/TAZ:TEAD interaction [,,,,,,,,].
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Yap1
  - Tafazzin
  - Wwtr1
  - Tnks
  - Amot
  - Src
  - Ptk2
  - Hps3
  - Pik3r1
  - ras
  - Hras
  - Kras
  - Rem1
  - Mst1
  - Stk4
  - Sav1
  - Lats1
  - Mob1a
  - Egfr
  - Gpbar1
  - Pdk1
  - Pdpk1
  - Zhx2
  - Mdk
  - Ephb2
  - Mapk1
  - Rho
  - Rhod
  - Ea2
  - yki
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - hpo
  - hp
  - Taz
  - Dis3
  - Src42A
  - Csk
  - Src64B
  - Fak
  - Coa
  - sm
  - sd
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Ras64B
  - Ras85D
  - Mst57Dc
  - Mst57Db
  - Mst57Da
  - sav
  - wts
  - Oamb
  - ww
  - Raf
  - Dsor1
  - Mtk
  - Erk7
  - rl
  - rho
  - Bx
  - Rho1
  - Lcp65Ab1
  - YAP1
  - TAFAZZIN
  - WWTR1
  - TNKS
  - AMOT
  - SRC
  - FGR
  - FYN
  - YES1
  - PTK2
  - TEAD1
  - TEAD2
  - TEAD3
  - TEAD4
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - KRAS
  - HRAS
  - NRAS
  - MST1
  - STK4
  - SAV1
  - LATS1
  - MOB1A
  - EGFR
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - PDK1
  - PDPK1
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - RHO
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - tafazzin
  - tnksa
  - amot
  - src
  - ptk2ab
  - napbb
  - rab1ab
  - mst1
  - sav1
  - lats1
  - mob1a
  - egfra
  - pdk1
  - rnd2
---
